Your browser doesn't support javascript.
loading
Infantile hypercalcemia type 1 (HCINF1): a rare disease resulting in nephrolithiasis and nephrocalcinosis caused by mutations in the vitamin D catabolic enzyme, CYP24A1.
Jones, G; Kaufmann, M; St-Arnaud, R.
Affiliation
  • Jones G; Department of Biomedical & Molecular Sciences, Queen's University, Kingston, ON, Canada. gj1@queensu.ca.
  • Kaufmann M; Department of Biomedical & Molecular Sciences, Queen's University, Kingston, ON, Canada.
  • St-Arnaud R; Shriners Hospitals for Children-Canada and McGill University, Montreal, QC, Canada.
J Endocrinol Invest ; 2024 May 23.
Article in En | MEDLINE | ID: mdl-38780860
ABSTRACT
Infantile hypercalcemia type 1 (HCINF1), formerly known as Lightwood syndrome, is a subtype of hypercalcemia caused by loss-of-function biallelic mutations in the vitamin D catabolic enzyme, CYP24A1, which 24-hydroxylates the hormone 1,25-(OH)2D3. This short review focuses on the main features of the HCINF1 disease; emerging knowledge of the structure and function of the cytochrome P450, CYP24A1 and the location of inactivating mutations; the development of a rapid LC-MS/MS-based laboratory test for defective 24-hydroxylation; and future implications for bioanalytical assay and treatment of all types of vitamin D-related hypercalcemic conditions.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Endocrinol Invest Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Endocrinol Invest Year: 2024 Document type: Article